Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplant Recipients: A Global Perspective

PREFACE
This report, cosponsored by the CIBMTR, NMDP, EBMT, ASBMT, CBMTG, IDSA, SHEA, AMMI, CDC, and the Health Resources and Services Administration, represents an update of the guidelines published in 2000 for preventing infections among hematopoietic cell transplant (HCT) recipients [1]. An international group of experts in infectious diseases, hematopoietic cell transplantation, and public health worked together to compile this document with four goals in mind: 1) to summarize the current available data in the field; 2) to provide evidence-based recommendations regarding prevention of infectious complications among HCT patients; 3) to serve as a reference for health care providers worldwide who care for HCT recipients; and, 4) to serve as a reference for HCT recipients and their non-medical caregivers. In updating these guidelines, the committee sought to summarize the currently available data and present them as concisely as possible in an evidence-based fashion.

Provided by : Dr alaa Aljuaid